Aurinia Pharmaceuticals, Inc. (AUPH)
16.86
-0.47
(-2.71%)
USD |
NASDAQ |
Oct 23, 16:00
16.86
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Market Cap : 2.241B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.241B |
| October 22, 2026 | 2.303B |
| October 21, 2026 | 2.246B |
| October 20, 2026 | 2.225B |
| October 19, 2026 | 2.192B |
| October 16, 2026 | 2.194B |
| October 15, 2026 | 2.224B |
| October 14, 2026 | 2.208B |
| October 13, 2026 | 2.174B |
| October 12, 2026 | 2.200B |
| October 09, 2026 | 2.213B |
| October 08, 2026 | 2.156B |
| October 07, 2026 | 2.128B |
| October 06, 2026 | 2.085B |
| October 05, 2026 | 2.089B |
| October 02, 2026 | 2.104B |
| October 01, 2026 | 2.120B |
| September 30, 2026 | 2.152B |
| September 29, 2026 | 2.182B |
| September 28, 2026 | 2.196B |
| September 25, 2026 | 2.185B |
| September 24, 2026 | 2.206B |
| September 23, 2026 | 2.180B |
| September 22, 2026 | 2.216B |
| September 21, 2026 | 2.208B |
| Date | Value |
|---|---|
| September 18, 2026 | 2.246B |
| September 17, 2026 | 2.254B |
| September 16, 2026 | 2.254B |
| September 15, 2026 | 2.144B |
| September 14, 2026 | 2.181B |
| September 11, 2026 | 2.140B |
| September 10, 2026 | 2.141B |
| September 09, 2026 | 2.160B |
| September 08, 2026 | 2.136B |
| September 04, 2026 | 2.137B |
| September 03, 2026 | 2.142B |
| September 02, 2026 | 2.165B |
| September 01, 2026 | 2.133B |
| August 31, 2026 | 2.141B |
| August 28, 2026 | 2.165B |
| August 27, 2026 | 2.190B |
| August 26, 2026 | 2.198B |
| August 25, 2026 | 2.226B |
| August 24, 2026 | 2.202B |
| August 21, 2026 | 2.213B |
| August 20, 2026 | 2.295B |
| August 19, 2026 | 2.149B |
| August 18, 2026 | 2.033B |
| August 17, 2026 | 2.032B |
| August 14, 2026 | 2.056B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| enGene Therapeutics, Inc. | 104.54M |
| Medicus Pharma Ltd. | 150.42M |
| Xenon Pharmaceuticals, Inc. | 3.419B |
| Psyence Biomedical Ltd. | 9.552M |
| Agenus, Inc. | 269.76M |
Market Cap Related Metrics
| PE Ratio | 7.370 |
| PS Ratio | 7.379 |
| PEG Ratio | 0.0169 |
| Price to Book Value | 3.644 |
| Price to Free Cash Flow | 13.20 |
| Price | 16.86 |
| Earnings Yield | 13.57% |
| PEGY Ratio | 0.0169 |
| Operating PE Ratio | 16.34 |
| Normalized PE Ratio | 7.370 |